CLYM Climb Bio Inc: Forvard P/S multiplikatori
Climb Bio Inc murakkab yallig'lanish patologiyalari uchun ilg'or terapiyalarni ishlab chiqadi. Kompaniyaga tegishli P/S kutsivlari bozor optimizmini aks ettiradi, bunda ko'rsatkichi baholash parametrining holatini belgilaydi. Rahbariyat antitanachlar ishlab chiqish uchun resurslarni qat'iy nazorat qiladi. Biznes muvaffaqiyati budigalimabni sinovlarning so'nggi bosqichlariga olib chiqish va yirik hamkorlarni jalb qilishga asoslangan.
Climb Bio, Inc (CLYM) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- qarzdorlik darajasi va moliyaviy likvidlik ma'lumotlari:
Qarzning xususiy kapitalga nisbati Climb Bio Inc|CLYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Climb Bio Inc|CLYM - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Climb Bio, Inc|CLYM - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari Climb Bio|Tezkor likvidlik koeffitsiyenti climbbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CLYM - Sof moliyaviy natija|Kutilayotgan foyda Climb Bio Inc|CLYM - Kapitalizatsiyaning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Climb Bio, Inc.|CLYM - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori Climb Bio, Inc|CLYM - Amortizatsiya chegirilmasdan oldingi operatsion daromad|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Climb Bio|CLYM - So'nggi 12 oy davomida bir aksiya uchun foyda|Choraklik EPS foyda o'sishi climbbio.com|CLYM - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Climb Bio Inc
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning jamlanma tahliliyoti:Climb Bio (CLYM)
Climb Bio Inc (CLYM) dori vositalarini ishlab chiqishdagi etik ESG standartlari tartibga soluvchi xavflarni yumshatadi va kelajakdagi pul oqimlari barqarorligiga bevosita ta'sir ko'rsatadi. Forward P/S koeffitsiyenti joriy bozor kapitalizatsiyasini kutilayotgan daromadlar bilan solishtiradi, bu esa investorlarga multiplikatorlar siqilishi sur'atini va ushbu grafikda ko'rsatilganidek, talabning kamayishi holatida "qiymat tuzog'i" xavfini baholash imkonini beradi.
Muhim raqobatchilar
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA Corp (ADMA) - Forvard narx/daromad multiplikatori|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|IMVT (immunovant.com) - Narxning prognoz qilingan daromadga nisbati|KNSA (Kiniksa) - Forvard P/S multiplikatori|Grifols SA (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Forvard narx/daromad multiplikatori Celldex Corp CLDX|Forvard P/S multiplikatori AUPH (Aurinia Pharmaceuticals)|biocryst.com - Narxning prognoz qilingan daromadga nisbati|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics Inc)|PHVS: Forvard P/S multiplikatori|ABCL (AbCellera Corp) - Narxning prognoz qilingan daromadga nisbati|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|precigen.com (PGEN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Pharming Group (PHAR)|NKTR - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Upstream Bio Corp - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ZBIO|Immunome, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati gossamerbio.com GOSS|KalVista Pharmaceuticals, Inc. (KALV) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati SEPN|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Savara Pharma (SVRA)|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori anaptysbio.com ANAB|Narxning prognoz qilingan daromadga nisbati Astria Therapeutics, Inc. ATXS|enGene Holdings Inc - Narxning prognoz qilingan daromadga nisbati|RAPT: Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aerovate Therapeutics Inc|Aclaris Therapeutics (ACRS) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori kyvernatx.com|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences Ltd|Cabaletta Bio Inc. - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori VTYX|THTX (Theratechnologies, Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|Forvard P/S multiplikatori eledon.com ELDN|AGEN - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx ZURA (Zura Bio Ltd)|aTyr (ATYR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Adagene Inc.|IMA (ImageneBio) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Shattuck Therapeutics|Forvard narx/daromad multiplikatori EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori IMUX (Immunic)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Atara Biotherapeutics, Inc. (ATRA)|IFRX - Narxning prognoz qilingan daromadga nisbati|x4pharma.com (XFOR) - Forvard narx/daromad multiplikatori|adicetbio.com (ACET) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Celularity|Forvard narx/daromad multiplikatori INMB|Forvard P/S multiplikatori Barinthus Biotherapeutics Corp|Narxning prognoz qilingan daromadga nisbati Kezar Life Sciences (KZR)|sabbiotherapeutics.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori AKTX (Akari Therapeutics Plc)|Enlivex Therapeutics Ltd (ENLV) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Q32 Bio Corp - Forvard P/S multiplikatori|GeoVax Corp (GOVX) - Forvard narx/daromad multiplikatori|Edesa Biotech, Inc. (EDSA) - Narxning prognoz qilingan daromadga nisbati|IBIO (ibioinc.com) - Narxning prognoz qilingan daromadga nisbati|CARM (Carisma Therapeutics Inc) - Forvard P/S multiplikatori|XTL Biopharmaceuticals Ltd (XTLB) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics (BOLT)|Forvard narx/daromad multiplikatori hcwbiologics.com HCWB|Forvard P/S multiplikatori APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. - Narxning prognoz qilingan daromadga nisbati|ADTX: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx GRI (GRI Bio Inc)|XRTX: Forvard P/S multiplikatori|HIND (Vyome Therapeutics) - Narxning prognoz qilingan daromadga nisbati|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|indaptusrx.com (INDP) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|CALI - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Affimed N.V. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ALLK|HOOKIPA - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati OCEA|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Third Harmonic Bio Inc (THRD)
